BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24953434)

  • 1. IV nicotine self-administration in rats using a consummatory operant licking response: sensitivity to serotonergic, glutaminergic and histaminergic drugs.
    Cousins V; Rose JE; Levin ED
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():200-5. PubMed ID: 24953434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IV nicotine self-administration in rats using the consummatory operant licking response.
    Levin ED; Hampton D; Rose JE
    Physiol Behav; 2010 Dec; 101(5):755-8. PubMed ID: 20804779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextromethorphan interactions with histaminergic and serotonergic treatments to reduce nicotine self-administration in rats.
    Briggs SA; Hall BJ; Wells C; Slade S; Jaskowski P; Morrison M; Rezvani AH; Rose JE; Levin ED
    Pharmacol Biochem Behav; 2016 Mar; 142():1-7. PubMed ID: 26704812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats.
    Levin ED; Johnson JE; Slade S; Wells C; Cauley M; Petro A; Rose JE
    J Pharmacol Exp Ther; 2011 Sep; 338(3):890-6. PubMed ID: 21636655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D
    DiPalma D; Rezvani AH; Willette B; Wells C; Slade S; Hall BJ; Levin ED
    Pharmacol Biochem Behav; 2019 Jan; 176():16-22. PubMed ID: 30419272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotine.
    Palmatier MI; Liu X; Donny EC; Caggiula AR; Sved AF
    Neuropsychopharmacology; 2008 Aug; 33(9):2139-47. PubMed ID: 18046312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine H(1) antagonist treatment with pyrilamine reduces nicotine self-administration in rats.
    Levin ED; Slade S; Wells C; Pruitt M; Cousins V; Cauley M; Petro A; Hampton D; Rose J
    Eur J Pharmacol; 2011 Jan; 650(1):256-60. PubMed ID: 20951696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists.
    Batman AM; Munzar P; Beardsley PM
    Psychopharmacology (Berl); 2005 May; 179(2):393-401. PubMed ID: 15565434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control.
    Higgins GA; Silenieks LB; Rossmann A; Rizos Z; Noble K; Soko AD; Fletcher PJ
    Neuropsychopharmacology; 2012 Apr; 37(5):1177-91. PubMed ID: 22189292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic interactive treatments of serotonin 5HT
    Willette BKA; Nangia A; Howard S; DiPalma D; McMillan C; Tharwani S; Evans J; Wells C; Slade S; Hall BJ; Rezvani AH; Levin ED
    Pharmacol Biochem Behav; 2019 Nov; 186():172766. PubMed ID: 31470021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.
    Levin ED; Slade S; Johnson M; Petro A; Horton K; Williams P; Rezvani AH; Rose JE
    Eur J Pharmacol; 2008 Dec; 600(1-3):93-7. PubMed ID: 18950618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing effect of menthol on nicotine self-administration in rats.
    Biswas L; Harrison E; Gong Y; Avusula R; Lee J; Zhang M; Rousselle T; Lage J; Liu X
    Psychopharmacology (Berl); 2016 Sep; 233(18):3417-27. PubMed ID: 27473365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iptakalim attenuates self-administration and acquired goal-tracking behavior controlled by nicotine.
    Charntikov S; Swalve N; Pittenger S; Fink K; Schepers S; Hadlock GC; Fleckenstein AE; Hu G; Li M; Bevins RA
    Neuropharmacology; 2013 Dec; 75():138-44. PubMed ID: 23916479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of administration of the nicotinic acetylcholine receptor antagonist BTMPS, during nicotine self-administration, on lever responding induced by context long after withdrawal.
    Hall BJ; Pearson LS; Buccafusco JJ
    Neuropharmacology; 2010 Feb; 58(2):429-35. PubMed ID: 19772864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescent nicotine or cigarette smoke exposure changes subsequent response to nicotine conditioned place preference and self-administration.
    de la Peña JB; Ahsan HM; Botanas CJ; Sohn A; Yu GY; Cheong JH
    Behav Brain Res; 2014 Oct; 272():156-64. PubMed ID: 24991754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lorcaserin (Belviq
    Jacobs DS; Barkin CE; Kohut MR; Bergman J; Kohut SJ
    Drug Alcohol Depend; 2017 Dec; 181():94-101. PubMed ID: 29040827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine analog inhibition of nicotine self-administration in rats.
    Rowland NE; Robertson K; Soti F; Kem WR
    Psychopharmacology (Berl); 2008 Sep; 199(4):605-13. PubMed ID: 18536909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats.
    Yuan M; Malagon AM; Yasuda D; Belluzzi JD; Leslie FM; Zaveri NT
    Behav Brain Res; 2017 Aug; 333():251-257. PubMed ID: 28693859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of nicotine self-administration by chronic nicotine infusion with H1 histamine blockade in female rats.
    Levin ED; Hall BJ; Chattopadhyay A; Slade S; Wells C; Rezvani AH; Rose JE
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):3009-15. PubMed ID: 27318988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.
    Liu X; Caggiula AR; Yee SK; Nobuta H; Sved AF; Pechnick RN; Poland RE
    Neuropsychopharmacology; 2007 Mar; 32(3):710-8. PubMed ID: 16794568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.